Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
HNO|February 26, 2016
[Immunomodulation as innovative therapy for head and neck tumors : Current developments]P J Schuler, J C Doescher, S Laban, et al.
HNO|November 2, 2012
[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting]S Schöpper, S Laban, B Güldenzoph, et al.
HNO|November 14, 2018
[Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting]S Ott, T Wiegel, S Laban, et al.
HNO|October 25, 2024
[Update on HPV-associated head and neck cancers-highlights of the 2024 ASCO Annual Meeting]S J Sharma, J P Klussmann, J Döscher, et al.
HNO|October 30, 2019
[Studies on radiotherapy of head and neck cancer : Highlights of the 2019 ASCO Annual Meeting]S Ott, T Wiegel, T K Hoffmann, et al.
Cell Death & Disease|March 14, 2015
Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1AM Elbaz, N Yanay, S Laban, et al.
HNO|November 9, 2019
[Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2019 ASCO Meeting]H B Zech, S Laban, P Schafhausen, et al.
Carbohydrate Research|August 15, 1990
Two-dimensional 1H-, 13C-, and 31P-nuclear magnetic resonance and molecular-mechanics investigation of D-fructose 2,6-bisphosphateR J Voll, S Ramaprasad, D Vargas, et al.
HNO|November 2, 2012
[The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting]S Laban, V Zielinski, C-J Busch, et al.
HNO|November 9, 2019
[Update on HPV-associated head and neck cancer-highlights from the 2019 ASCO Annual Meeting]S Tribius, N Würdemann, S Laban, et al.
Pageof 5